Wenqiang Liu

5.6k citations
135 papers · 2.9k indexed · 1 hit paper · h-index 23
Topics
Pluripotent Stem Cells Research (19 papers)CRISPR and Genetic Engineering (17 papers)Epigenetics and DNA Methylation (17 papers)

In The Last Decade

Wenqiang Liu

123 papers receiving 2.8k citations

Hit Papers

Distinct features of H3K4me3 and H3K27me3 chromatin domai...20162026201920222016100200300400500

Peers

Wenqiang Liu
Comparison fields: 5 of 131
  • Molecular Biology 2.2k
  • Public Health, Environmental and Occupational Health 377
  • Genetics 324
  • Cancer Research 310
  • Plant Science 231
Replace Yanli Zhang with:
Yanli Zhang China
Rabih Murr France
Yuxuan Zheng China
Kristy Brown United States
Wei Yu China
Yao Li China
Junjiu Huang China
Shuzhen Chen United States
Elena Dellambra Italy
Chen Li China
Wenqiang Liu relative to Yanli Zhang China Yanli Zhang's profile →
Citations per field
00.5×
Yanli Zhang · 1×
Citations per year

Countries citing papers authored by Wenqiang Liu

Since Specialization
Citations

This map shows the geographic impact of Wenqiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqiang Liu more than expected).

Fields of papers citing papers by Wenqiang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqiang Liu. The network helps show where Wenqiang Liu may publish in the future.

Co-authorship network of co-authors of Wenqiang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqiang Liu. A scholar is included among the top collaborators of Wenqiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqiang Liu. Wenqiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 2
5 2
6 3
7 1
8 8
9 2
10 17
11 1
12 1
13 4
14 7
15 8
16 2
17 11
18 22
19 18
20 18

About Wenqiang Liu

Wenqiang Liu is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine, having authored 135 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (19 papers), CRISPR and Genetic Engineering (17 papers) and Epigenetics and DNA Methylation (17 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Aging (38 citations) and Cancer Research (310 citations). Wenqiang Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shaorong Gao, Xiaochen Kou, Yawei Gao, Yanhong Zhao, Jiayu Chen, Yong Zhang, Chenfei Wang, Xiaoyu Liu, Chong Li and Hong Wang. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026